spacer
home > > autumn 2003 > patient diaries: a possible source of data inconsistency?
PUBLICATIONS


Patient Diaries: A Possible Source of Data Inconsistency?

Patient diaries constitute one of the most relevant sources of direct information in clinical research. They contain information provided directly by the most important participant in the clinical trial: the patient. This fact makes the diaries a key element when retrieving and analysing data, but also means that the quality and relevance of these data differs considerably from those recorded in the investigators' standard CRF.

When using patient diaries, it is the patient who fills out the diary forms with the information they consider to be accurate. Therefore, this information cannot be evaluated with the same confidence level as those provided by clinical research or health care professionals.

One of the most relevant problems raised from the use of patient diaries in clinical studies is the fact that inconsistencies are sometimes found between the data introduced in the diaries by the patients and those entered in the CRF by the investigator or the study co-ordinator. This problem is even more serious when patient diaries are used in the scope of multicentre, multinational and multilingual studies, when an additional possible bias can be introduced by the use of the various translated versions of the diaries.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
By Sebastián Pacios Merino, Vice President of Operations, Countries Group, PRA International

Sebastián Pacios Merino is Vice President of Operations, Countries Group at PRA International. Beginning his career as a GP in the Spanish national health service, Sebasti‡n has since moved into clinical research. His roles have included Medical Translator/Advisor for SANED, EDICOMPLET, Project Manager at ITEM-PHARMA and Clinical Research Manager at Verum ITEM-PHARMA/Phoenix International Espa–a, where he later became Director. He has experience in a broad range of therapeutic areas including CNS neurology, gastroenterology, dermatology, cardiology and infectious diseases such as HIV. Sebastián has a degree in Medicine from the Facultad de Medicina, Universidad Aut—noma de Madrid, Spain.

spacer
Sebastián Pacios Merino
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Leading pharma packaging companies commit to supply for Covid-19 fight

The CEOs of Gerresheimer, Stevanato Group, and SCHOTT are committed to ensuring ample supply of pharmaceutical containers for any Covid-19 vaccine and treatment that is developed, and that no patient shall be left behind, no matter what region of the world they live in. Also, the companies will make every effort to support the pharma industry’s’ priorities for overall medication supply in addition to Covid-19 drugs. Each of the three companies manufactures billions of type-1 borosilicate glass vials, the most proven and most widely available material used to store and deliver vaccines around the world. They are making the statement to provide confidence in the global pharmaceutical supply chain in times of uncertainty.
More info >>

White Papers

BioT ULT Transporter

BioCision

The growth of biobanking, cell therapy, and complex biopharmaceutical therapies like cancer vaccines has created a strong need for products and processes to ensure the stability of temperature­-sensitive biospecimens. Proper collection, handling, characterization, packaging and shipping of these materials is critical, as poor sample handling impacts researchers working on discovery with patient samples, as well as clinicians treating patients with cutting edge therapies. This white paper describes in detail the BioCision BioT™ ULT Transporter, the first-of-its-kind dry ice-based portable cooling system that maintains a stable -75° to -50°C environment for over 24 hours on one charge of dry ice, enabling reliable handling and transfer of valuable temperature-sensitive biospecimens as part of a larger cold chain standardization process.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement